Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
24.53
+0.54 (2.25%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Ultragenyx Pharmaceutical Employees
Ultragenyx Pharmaceutical had 1,371 employees as of December 31, 2025. The number of employees increased by 77 or 5.95% compared to the previous year.
Employees
1,371
Change (1Y)
77
Growth (1Y)
5.95%
Revenue / Employee
$490,883
Profits / Employee
-$419,402
Market Cap
2.41B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,784 |
| Sarepta Therapeutics | 835 |
| Ascentage Pharma Group International | 767 |
| ADMA Biologics | 647 |
| Adaptive Biotechnologies | 624 |
| Tarsus Pharmaceuticals | 370 |
| Celldex Therapeutics | 198 |
| Definium Therapeutics | 106 |
RARE News
- 4 days ago - Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 25 days ago - DEADLINE NEXT WEEK: Berger Montague Advises Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) Investors to Contact the Firm Before April 6, 2026 - PRNewsWire
- 4 weeks ago - Ultragenyx Announces FDA Clearance of Investigational New Drug (IND) Application for UX016, a Sialic Acid Prodrug for the Treatment of GNE Myopathy - GlobeNewsWire
- 4 weeks ago - Bragar Eagel & Squire, P.C. Reminds Ultragenyx (NASDAQ: RARE) Investors of the Upcoming April 6th Lead Plaintiff Deadline and Urges Investors to Contact the Firm - GlobeNewsWire
- 6 weeks ago - Ultragenyx's Gene Therapy Study Shows Ammonia Reduction In Rare Metabolic Disorder - Benzinga
- 6 weeks ago - Ultragenyx's gene therapy helps control ammonia levels in late-stage study - Reuters
- 6 weeks ago - Ultragenyx Pharmaceutical Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Ultragenyx Pharmaceutical Transcript: Barclays 28th Annual Global Healthcare Conference - Transcripts